Biocytogen Pharmaceuticals (Beijing) Co., Ltd. has filed its list of directors and their roles with the Hong Kong Stock Exchange. The Board includes Dr. Shen Yuelei, serving as Chairman, CEO, and General Manager, alongside Dr. Ni Jian as Executive Director. Non-executive Directors are Mr. Wei Yiliang, Dr. Zhou Kexiang, and Ms. Zhang Leidi. The Board also features Independent Non-executive Directors Mr. Hua Fengmao, Dr. Yu Changyuan, and Ms. Liang Xiaoyan, as well as Employee Director Ms. Li Yan. Committee memberships were also detailed: Dr. Shen Yuelei chairs the Strategy Development Committee and is a member of the Nomination Committee; Dr. Ni Jian is a member of the Remuneration and Evaluation Committee; Mr. Wei Yiliang sits on the Audit and Strategy Development Committees; Dr. Zhou Kexiang and Ms. Zhang Leidi are members of the Strategy Development Committee. Mr. Hua Fengmao chairs the Remuneration and Evaluation Committee and is a member of the Audit and Nomination Committees. Dr. Yu Changyuan chairs the Nomination Committee and is a member of the Audit and Remuneration and Evaluation Committees. Ms. Liang Xiaoyan chairs the Audit Committee and is a member of the Remuneration and Evaluation and Nomination Committees.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biocytogen Pharmaceuticals Beijing Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251210-11950359), on December 09, 2025, and is solely responsible for the information contained therein.
Comments